Virtu Financial LLC Roivant Sciences Ltd. Transaction History
Virtu Financial LLC
- $1.43 Billion
- Q2 2024
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
318Shares Held
495MCall Options Held
1.29MPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$843 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$817 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$788 Million72.99% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$418 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$346 Million0.02% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.32B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...